Organization
Bio-Innova
16 clinical trials
Clinical trial
A Bioequivalence Study of Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg in Healthy Thai Volunteers Under Fed ConditionStatus: Not yet recruiting, Estimated PCD: 2024-05-29
Clinical trial
A Bioequivalence Study of Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-06-22
Clinical trial
A Bioequivalence Study of Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets in Healthy Thai Adult Volunteers Under Fed Condition.Status: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Bioequivalence Study of Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator in Healthy Thai Volunteers Under Fed Condition.Status: Not yet recruiting, Estimated PCD: 2024-07-14
Clinical trial
A Bioequivalence Study of Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets in Healthy Thai Male Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2025-03-11
Clinical trial
A Bioequivalence Study of Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg, in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-04-05
Clinical trial
A Bioequivalence Study of Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule in Healthy Thai Male Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-11-18
Clinical trial
A Bioequivalence Study of Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin® in Healthy Thai Female Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-04-29
Clinical trial
A Bioequivalence Study of a Randomized, Open-label, Single Dose, Two-way Crossover Design With Two-period, Two-treatment and Two-sequence of Ticagrelor Tablets 90 mg Relative to Originator in Healthy Thai Volunteers Under Fasting Condition.Status: Not yet recruiting, Estimated PCD: 2024-07-19
Clinical trial
A Bioequivalence Study of a Randomized, Open-label, Single Dose, Two-way Crossover Design With Two-period, Two-treatment and Two-sequence of Febuxostat 80 mg Tablets Relative to Feburic® in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Bioequivalence Study of Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg) in Healthy Thai Female Volunteers Under Fasting Condition.Status: Not yet recruiting, Estimated PCD: 2024-09-05
Clinical trial
A Bioequivalence Study of Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-09-28
Clinical trial
A Bioequivalence Study of Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets in Healthy Thai Volunteers Under Fed ConditionStatus: Not yet recruiting, Estimated PCD: 2024-11-19
Clinical trial
A Bioequivalence Study of a Randomized, Open-label, Single Dose, Two-way Crossover Design With Two-period, Two-treatment and Two-sequence of Dapagliflozin Tablet 10 mg Relative to Forxiga® in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-08-25
Clinical trial
A Bioequivalence Study of Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-08-17
Clinical trial
A Bioequivalence Study of Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz® in Healthy Thai Female Volunteers Under Fasting ConditionStatus: Recruiting, Estimated PCD: 2024-04-04